For example, in muscle cells of individuals with T2D and obesity, troglitazone increases the expression of PPAR-γ at mRNA and protein levels, as well as increases the activity of glycogen synthase [32]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.